Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2013 Jul 5;12(9):1774–1782. doi: 10.1158/1535-7163.MCT-12-1023

Figure 6.

Figure 6

Combination therapy inhibition of xenograft tumor growth. HT-29 tumor xenograft growth is inhibited slightly by independent drug treatments, but only the combination exhibits a significant (p = 0.053) delay in tumor growth. Arrows indicate days when doses were administered to all groups. *One mouse in the Combo group was euthanized following day 7 dosing and not used for statistical analysis.